comparemela.com

Latest Breaking News On - Aytu biopharma - Page 5 : comparemela.com

Aytu BioPharma to Present at the Emerging Growth Conference on April ...

Aytu BioPharma to Present at the Emerging Growth Conference on April ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Denver
Colorado
United-states
Josh-disbrow
Mark-oki
Roger-weisslytham
Aytu-biopharma-inc
Company-or-aytu
Financial-officeraytu-biopharma-inc
News-network
Emerging-growth-conference
Aytu-biopharma

Earnings Scheduled For February 14, 2024 - Arch Capital Group (NASDAQ:ACGL), Adaptive Biotechnologies (NASDAQ:ADPT)

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.

Louisiana
United-states
Albemarle
American
Palomar-hldgs
Generac-hldgs
Kraft-heinz
Corporacion-inmobiliaria
Aytu-biopharma
Wyndham-hotels-resorts
Independence-realty-trust
Nu-skin-enterprises

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During ...

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Q2 2024 operating income of $2.4 millionQ2 2024 net loss of $0.2 million and adjusted EBITDA1 of $5.1 millionQ2 2024 Rx Segment net revenue of $18.7 million, net income of $0.7 million, and adjusted EBITDA of $5.5 millionQ2 2024 ADHD Portfolio net revenue up 49% compared to Q2 2023$19.5 million cash balance at Decem.

United-states
Denver
Colorado
Roger-weiss
Josh-disbrow
Mark-oki
Aytu-rxconnect
Consumer-health-segment
Company-consumer-health-segment
Consumer-health
Aytu-biopharma-inc
Securities-exchange

Aytu BioPharma (AYTU) Set to Announce Earnings on Wednesday

Aytu BioPharma (NASDAQ:AYTU – Get Free Report) is scheduled to release its earnings data on Wednesday, February 14th. Aytu BioPharma (NASDAQ:AYTU – Get Free Report) last issued its quarterly earnings results on Tuesday, November 14th. The company reported ($1.48) earnings per share (EPS) for the quarter. The firm had revenue of $22.10 million for the […]

United-states
Aytu-biopharma
Millennium-management
Dimensional-fund-advisors
Renaissance-technologies
Prudential-financial-inc
Aytu-biopharma-inc
Consumer-health
Commonwealth-equity-services
Get-free-report
Equity-services
Fund-advisors

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.